FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137268919> ?p ?o ?g. }

• W3137268919 endingPage "958" @default.
• W3137268919 startingPage "946" @default.
• W3137268919 abstract "ATTRACTION-2 demonstrated that nivolumab improved overall survival (OS) vs placebo in patients with advanced gastric cancer treated with ≥ 2 chemotherapy regimens. However, its long-term efficacy and outcome of treatment beyond progression (TBP) with nivolumab have not been clarified.The 3-year follow-up data were collected. A subset analysis was performed to explore the efficacy of TBP by assessing postprogression survival (PPS) after the first event of disease progression.Overall, 493 patients were randomized (2:1) to receive nivolumab (n = 330) or placebo (n = 163). With a median follow-up of 38.5 (range 36.1-47.5) months, OS of the nivolumab group was significantly longer compared to the placebo group (median 5.3 vs 4.1 months; 3-year survival rate, 5.6% vs 1.9%; hazard ratio [HR], 0.62 [95% confidence interval (CI) 0.50-0.75], P < 0.0001). The median OS of responders (n = 32) who achieved complete response or partial response was 26.7 months and the 3-year survival rate was 35.5% in the nivolumab group. Overall, 109 patients in the nivolumab group and 37 patients in the placebo group received TBP. PPS tended to be longer in the nivolumab group vs placebo group (median 5.8 vs 4.5 months; HR [95% CI], 0.69 [0.47-1.01], P = 0.057). In contrast, PPS was similar between both treatment groups in non-TBP patients (median 2.3 vs 2.2 months; HR 0.90, P = 0.42).Long-term efficacy of nivolumab was confirmed at the 3-year follow-up, and a survival benefit of TBP with nivolumab was suggested. Biomarkers for selecting patients suitable for TBP with nivolumab should be identified in the future." @default.
• W3137268919 created "2021-03-29" @default.
• W3137268919 creator A5004641991 @default.
• W3137268919 creator A5010090426 @default.
• W3137268919 creator A5014734397 @default.
• W3137268919 creator A5026090288 @default.
• W3137268919 creator A5029101744 @default.
• W3137268919 creator A5033552897 @default.
• W3137268919 creator A5035238172 @default.
• W3137268919 creator A5040552693 @default.
• W3137268919 creator A5041844936 @default.
• W3137268919 creator A5042323474 @default.
• W3137268919 creator A5051301531 @default.
• W3137268919 creator A5056014331 @default.
• W3137268919 creator A5057554500 @default.
• W3137268919 creator A5058524907 @default.
• W3137268919 creator A5062251564 @default.
• W3137268919 creator A5062301570 @default.
• W3137268919 creator A5065244228 @default.
• W3137268919 creator A5073330859 @default.
• W3137268919 creator A5074290142 @default.
• W3137268919 creator A5082832235 @default.
• W3137268919 creator A5083889178 @default.
• W3137268919 creator A5084525824 @default.
• W3137268919 creator A5086469886 @default.
• W3137268919 creator A5087768741 @default.
• W3137268919 creator A5091587460 @default.
• W3137268919 date "2021-03-20" @default.
• W3137268919 modified "2023-10-05" @default.
• W3137268919 title "Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab" @default.
• W3137268919 cites W2019607817 @default.
• W3137268919 cites W2097995306 @default.
• W3137268919 cites W2100158834 @default.
• W3137268919 cites W2101571970 @default.
• W3137268919 cites W2128035403 @default.
• W3137268919 cites W2156353875 @default.
• W3137268919 cites W2529484692 @default.
• W3137268919 cites W2606976048 @default.
• W3137268919 cites W2725298133 @default.
• W3137268919 cites W2750862728 @default.
• W3137268919 cites W2763064222 @default.
• W3137268919 cites W2790568323 @default.
• W3137268919 cites W2791043965 @default.
• W3137268919 cites W2793126547 @default.
• W3137268919 cites W2806614796 @default.
• W3137268919 cites W2806832126 @default.
• W3137268919 cites W2883552436 @default.
• W3137268919 cites W2897154408 @default.
• W3137268919 cites W2898510820 @default.
• W3137268919 cites W2906523032 @default.
• W3137268919 cites W2928722477 @default.
• W3137268919 cites W2938997009 @default.
• W3137268919 cites W2941779578 @default.
• W3137268919 cites W2947739783 @default.
• W3137268919 cites W2955839328 @default.
• W3137268919 cites W2970420765 @default.
• W3137268919 cites W2994683483 @default.
• W3137268919 cites W2994968455 @default.
• W3137268919 cites W2997536960 @default.
• W3137268919 cites W3043356023 @default.
• W3137268919 cites W3082736986 @default.
• W3137268919 cites W3088611248 @default.
• W3137268919 cites W3089110714 @default.
• W3137268919 doi "https://doi.org/10.1007/s10120-021-01173-w" @default.
• W3137268919 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8205916" @default.
• W3137268919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33743112" @default.
• W3137268919 hasPublicationYear "2021" @default.
• W3137268919 type Work @default.
• W3137268919 sameAs 3137268919 @default.
• W3137268919 citedByCount "50" @default.
• W3137268919 countsByYear W31372689192021 @default.
• W3137268919 countsByYear W31372689192022 @default.
• W3137268919 countsByYear W31372689192023 @default.
• W3137268919 crossrefType "journal-article" @default.
• W3137268919 hasAuthorship W3137268919A5004641991 @default.
• W3137268919 hasAuthorship W3137268919A5010090426 @default.
• W3137268919 hasAuthorship W3137268919A5014734397 @default.
• W3137268919 hasAuthorship W3137268919A5026090288 @default.
• W3137268919 hasAuthorship W3137268919A5029101744 @default.
• W3137268919 hasAuthorship W3137268919A5033552897 @default.
• W3137268919 hasAuthorship W3137268919A5035238172 @default.
• W3137268919 hasAuthorship W3137268919A5040552693 @default.
• W3137268919 hasAuthorship W3137268919A5041844936 @default.
• W3137268919 hasAuthorship W3137268919A5042323474 @default.
• W3137268919 hasAuthorship W3137268919A5051301531 @default.
• W3137268919 hasAuthorship W3137268919A5056014331 @default.
• W3137268919 hasAuthorship W3137268919A5057554500 @default.
• W3137268919 hasAuthorship W3137268919A5058524907 @default.
• W3137268919 hasAuthorship W3137268919A5062251564 @default.
• W3137268919 hasAuthorship W3137268919A5062301570 @default.
• W3137268919 hasAuthorship W3137268919A5065244228 @default.
• W3137268919 hasAuthorship W3137268919A5073330859 @default.
• W3137268919 hasAuthorship W3137268919A5074290142 @default.
• W3137268919 hasAuthorship W3137268919A5082832235 @default.
• W3137268919 hasAuthorship W3137268919A5083889178 @default.
• W3137268919 hasAuthorship W3137268919A5084525824 @default.
• W3137268919 hasAuthorship W3137268919A5086469886 @default.
• W3137268919 hasAuthorship W3137268919A5087768741 @default.

• next